CooperCompanies Announces Release Date for Second Quarter 2021
CooperCompanies (NYSE: COO) will release its second quarter 2021 financial results on June 3, 2021, at 4:15 PM ET. A conference call will follow at 5:00 PM ET to discuss these results and corporate developments. Participants can join the call by dialing 855-643-4430 (U.S.) or 707-294-1332 (International), using the passcode 'Cooper'. A live webcast will also be available on their Investor Relations website, with a transcript archived for 12 months. The call recording will be accessible from June 3, 8:00 PM ET through June 10, 2021.
- Scheduled release of Q2 2021 financial results on June 3, indicating ongoing corporate operations.
- Conference call planned for discussing financial performance, promoting transparency with investors.
- None.
SAN RAMON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release second quarter 2021 financial results on Thursday, June 3, 2021, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a minimum of 12 months.
A recording of the call will be available beginning at 8:00 PM ET on June 3, 2021 through June 10, 2021. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 266737.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
When will CooperCompanies release its Q2 2021 financial results?
What is the purpose of the conference call on June 3, 2021?
How can I listen to the CooperCompanies conference call?
Is there a way to access the recording of the conference call?